Director/PDMR Share Dealings
Director/PDMR Share Dealings
Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Graham Hetherington was granted on September 27, 2013, under the Shire Sharesave Scheme, an option over 467 ordinary shares at an exercise price of £19.24 per share.
This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.
Tony Guthrie
Deputy Company Secretary
For further information please contact:
Investor Relations
Eric Rojas
[email protected]
+1 781 482 0999
Sarah Elton-Farr
[email protected]
+44 1256 894157
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.